Neoadjuvant Therapy in Resectable Pancreatic Cancer: Immortal Time Bias and Its Correction
- PMID: 28135147
- DOI: 10.1200/JCO.2016.71.2273
Neoadjuvant Therapy in Resectable Pancreatic Cancer: Immortal Time Bias and Its Correction
Comment in
-
Reply to J. Bergquist et al and T.-Y. Lai et al.J Clin Oncol. 2017 May 10;35(14):1624-1625. doi: 10.1200/JCO.2016.71.3891. Epub 2017 Jan 30. J Clin Oncol. 2017. PMID: 28135146 No abstract available.
Comment on
-
Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis.J Clin Oncol. 2017 Feb 10;35(5):515-522. doi: 10.1200/JCO.2016.68.5081. Epub 2016 Sep 30. J Clin Oncol. 2017. PMID: 27621388
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
